Osteoprotegerin and bone mineral density in hemodialysis patients

Osteoprotegerin Ligand Is a Cytokine that Regulates Osteoclast Differentiation and Activation

David L. Lacey, Emma Timms, Hong‐Lin Tan et al. · Cell · 1998 · 5.4K citations · Full text

Inflammation, Osteoprotegerin Ligand, Sclerostin +13

Osteoprotegerin: A Novel Secreted Protein Involved in the Regulation of Bone Density

W. Scott Simonet, Dave Lacey, Colin R. Dunstan et al. · Cell · 1997 · 5.1K citations · Full text

Sclerostin, Biochemistry, Bone Morphogenic Protein +13

Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL

Hisataka Yasuda, Nobuyuki Shima, N. Nakagawa et al. · Proceedings of the National Academy of Sciences · 1998 · 4.2K citations · Full text

Osteoprotegerin/osteoclastogenesis-inhibitory Factor, Sclerostin, Tumor Microenvironment +14

K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease

Shaul G. Massry, Jack W. Coburn, Glenn M. Chertow et al. · Data Archiving and Networked Services (DANS) · 2003 · 2.5K citations

Hemodialysis, Urology, Renal Disease +11

osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification

Nathan Bucay, Ildiko Sarosi, Colin R. Dunstan et al. · Genes & Development · 1998 · 2.5K citations · Full text

Mechanobiology, Metabolic Syndrome, Sclerostin +15